Deva Holding AS DEVA
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 4.49
- Price/Sales
- 175.48
- Dividend Yield (Trailing)
- 0.15%
- Dividend Yield (Forward)
- 0.24%
- Total Yield
- 0.15%
Company Profile
Deva Holding AS is a Turkey-based generic medicine manufacturer. It is engaged in manufacturing and marketing of medicinal products for human use and raw materials. The company also carries out the manufacturing of veterinary drugs, eau de cologne, and medical ampoules. It produces medicines for antineoplastic agents, cardiovascular system, dermatological products, nervous system, respiratory system, urogenital system, among others. It exports pharmaceuticals and pharmaceutical raw materials in countries including Switzerland, Germany, the Netherlands, the United Kingdom and others.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 2,931
- Website
- http://www.deva.com.tr
Comparables
Valuation
|
Metric
|
DEVA
|
300194
|
002864
|
|---|---|---|---|
Price/Earnings (Normalized) | 4.49 | 16.61 | 25.53 |
Price/Book Value | 1.34 | 1.14 | 1.94 |
Price/Sales | 175.48 | 1.81 | 3.00 |
Price/Cash Flow | 1,207.44 | 9.07 | 17.43 |
Price/Earnings
DEVA
300194
002864
Financial Strength
|
Metric
|
DEVA
|
300194
|
002864
|
|---|---|---|---|
Quick Ratio | 1.03 | 1.18 | 3.04 |
Current Ratio | 1.66 | 1.77 | 3.20 |
Interest Coverage | 2.16 | 10.96 | 13.86 |
Quick Ratio
DEVA
300194
002864
Profitability
|
Metric
|
DEVA
|
300194
|
002864
|
|---|---|---|---|
Return on Assets (Normalized) | 26.70% | 0.94% | 5.53% |
Return on Equity (Normalized) | 49.22% | 1.40% | 8.05% |
Return on Invested Capital (Normalized) | 38.23% | 1.12% | 6.48% |
Return on Assets
DEVA
300194
002864
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Zkwmldgvd | Tbdwthr | $78.2 Bil | |
ZTS
| Zoetis Inc Class A | Sblzqqjkly | Sftl | $78.0 Bil | |
HLN
| Haleon PLC ADR | Ywcqxvglf | Pmpb | $37.4 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Zzsxwrlqw | Kpbn | $19.1 Bil | |
VTRS
| Viatris Inc | Jvnvjvnfd | Vpzwt | $12.4 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Lshbjrnp | Xbt | $11.8 Bil | |
CTLT
| Catalent Inc | Jblhwgfx | Gcfgsl | $9.9 Bil | |
PRGO
| Perrigo Co PLC | Jzgyshzk | Cpgv | $3.8 Bil | |
CURLF
| Curaleaf Holdings Inc | Nlszmyhv | Dqt | $3.5 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Pxrtytwn | Vzqzqly | $3.2 Bil |